Pfizer (PFE) and GSK (GSK) settle RSV vaccine patent lawsuit, dismissing the case with prejudice. REad more here.

Pharmaceutical goods appear to be exempt from higher-rate tariffs introduced by President Trump in his 'Liberation Day' ...

GSK has reported new clinical data pointing to a benefit with its respiratory syncytial virus (RSV) vaccine Arexvy when used to treat a younger age group than the over-60s for whom it is approved.

When I’ve made mistakes on people, it’s usually for cultural reasons,” Walmsley told Norges Bank Investment Management CEO ...

GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...

Among the firms that are pursuing growth through acquisition is Mercer Advisors which recently added Vishria Bird Financial ...

GSK’s share price has fallen a long way from its one-year high, which has only increased the major undervaluation I'd seen in ...

Star Brands, the Leeds business behind Pink Stuff Miracle cleaning paste and sprays, is to be sold off by investment group ...

GSK Plc is studying a large group of elderly adults in the UK to determine if its blockbuster shingles vaccine reduces the risk of dementia, potentially opening the door to an expanded label for the ...

Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...